Cargando…

Risk factors for intraoperative hemorrhage of Type I neurofibromatosis

INTRODUCTION: Neurofibromatosis (NF) is an inherited disease and a benign tumor originating from nerve sheath cells. Neurofibromatosis type I (NF1) is the most common type, and most cases are characterized by neurofibromas. Neurofibromas in NF1 are mainly treated by surgery. Our study explores the r...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Qianqian, Qu, Siwei, Ma, Ning, Wang, Weixin, Chen, Sen, Yang, Zhe, Li, Yangqun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257818/
https://www.ncbi.nlm.nih.gov/pubmed/37301968
http://dx.doi.org/10.1186/s12893-023-02067-7
_version_ 1785057370823458816
author Gao, Qianqian
Qu, Siwei
Ma, Ning
Wang, Weixin
Chen, Sen
Yang, Zhe
Li, Yangqun
author_facet Gao, Qianqian
Qu, Siwei
Ma, Ning
Wang, Weixin
Chen, Sen
Yang, Zhe
Li, Yangqun
author_sort Gao, Qianqian
collection PubMed
description INTRODUCTION: Neurofibromatosis (NF) is an inherited disease and a benign tumor originating from nerve sheath cells. Neurofibromatosis type I (NF1) is the most common type, and most cases are characterized by neurofibromas. Neurofibromas in NF1 are mainly treated by surgery. Our study explores the risk factors for intraoperative hemorrhage in Type I neurofibromatosis patients who underwent neurofibroma resection. METHODS: A cross-sectional comparison of the patients who had undergone resection of neurofibroma for NF1. Data regarding patient characteristics and data about operative outcomes were recorded. The definition of intraoperative hemorrhage group was the intraoperative blood loss greater than 200 ml. RESULTS: Of 94 eligible patients, 44 patients were in the hemorrhage group and 50 patients were in the non-hemorrhage group. Multiple logistic regression analysis demonstrated that the area of excision, classification, surgical site, primary surgical, and organ deformation were significant independent predictors of hemorrhage. CONCLUSION: Early treatment can reduce the tumor cross-sectional area, avoid organ deformation, and reduce intraoperative blood loss. For plexiform neurofibroma or neurofibroma of the head and face, the amount of blood loss should be predicted correctly, and preoperative evaluation and blood preparation should be paid more attention to.
format Online
Article
Text
id pubmed-10257818
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-102578182023-06-12 Risk factors for intraoperative hemorrhage of Type I neurofibromatosis Gao, Qianqian Qu, Siwei Ma, Ning Wang, Weixin Chen, Sen Yang, Zhe Li, Yangqun BMC Surg Research INTRODUCTION: Neurofibromatosis (NF) is an inherited disease and a benign tumor originating from nerve sheath cells. Neurofibromatosis type I (NF1) is the most common type, and most cases are characterized by neurofibromas. Neurofibromas in NF1 are mainly treated by surgery. Our study explores the risk factors for intraoperative hemorrhage in Type I neurofibromatosis patients who underwent neurofibroma resection. METHODS: A cross-sectional comparison of the patients who had undergone resection of neurofibroma for NF1. Data regarding patient characteristics and data about operative outcomes were recorded. The definition of intraoperative hemorrhage group was the intraoperative blood loss greater than 200 ml. RESULTS: Of 94 eligible patients, 44 patients were in the hemorrhage group and 50 patients were in the non-hemorrhage group. Multiple logistic regression analysis demonstrated that the area of excision, classification, surgical site, primary surgical, and organ deformation were significant independent predictors of hemorrhage. CONCLUSION: Early treatment can reduce the tumor cross-sectional area, avoid organ deformation, and reduce intraoperative blood loss. For plexiform neurofibroma or neurofibroma of the head and face, the amount of blood loss should be predicted correctly, and preoperative evaluation and blood preparation should be paid more attention to. BioMed Central 2023-06-10 /pmc/articles/PMC10257818/ /pubmed/37301968 http://dx.doi.org/10.1186/s12893-023-02067-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Gao, Qianqian
Qu, Siwei
Ma, Ning
Wang, Weixin
Chen, Sen
Yang, Zhe
Li, Yangqun
Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title_full Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title_fullStr Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title_full_unstemmed Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title_short Risk factors for intraoperative hemorrhage of Type I neurofibromatosis
title_sort risk factors for intraoperative hemorrhage of type i neurofibromatosis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10257818/
https://www.ncbi.nlm.nih.gov/pubmed/37301968
http://dx.doi.org/10.1186/s12893-023-02067-7
work_keys_str_mv AT gaoqianqian riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT qusiwei riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT maning riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT wangweixin riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT chensen riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT yangzhe riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis
AT liyangqun riskfactorsforintraoperativehemorrhageoftypeineurofibromatosis